TB Alliance has announced the start of the first human trial of a new tuberculosis (TB) drug candidate, designated TBA-354. It is the first new TB drug candidate to begin a Phase 1 clinical trial ...
Focus is on designing therapies with shorter treatment regimens and streamlining development. The U.K. International Development Minister, Ivan Lewis, announced an £18 million, or $24.38 million, ...
First clinical trial to test a new all-oral regimen for extensively drug-resistant TB; Nix-TB is a critical step in the development of a universal treatment for all types of TB TB Alliance and its ...
TB alliance group and Unit Aid organizations announced the new fruit flavored drugs for children who are suffering from Tuberculosis (TB). The organizations recently announced that strawberry and ...
Welcome back to the TB Tipsheet 16 - a resource for journalists on tuberculosis (TB) that TB Alliance produces throughout the year. In the lead up to World TB Day on March 24, this edition begins by ...
Hosted on MSN
Sorbequiline, a new antibiotic likely to serve as a breakthrough in Tuberculosis treatment
Researchers in the TB Alliance informed the Union Conference on Lung Health in Copenhagen that Sorbequiline, a new antibiotic drug, caused stronger action against the deadly Tuberculosis-causing ...
NC-009 pan-phase 2 clinical trial to evaluate the safety and efficacy of a combination of TBAJ-876, pretomanid and linezolid for its potential to shorten and improve treatment for both drug-sensitive ...
ZURICH (Reuters) - Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from ...
TB alliance group and Unit Aid organizations announced the new fruit flavored drugs for children who are suffering from Tuberculosis (TB). New fruit flavored drugs for TB TB alliance group and Unit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results